CASE CCC IN THE NEWS
Immunotherapy Duo Ups Survival in Pancreatic Ca
MedPage Today - Jan 20, 2014
Looking beyond the preliminary nature of the study, the results "are exciting for a poor-prognosis cancer," said Smitha Krishnamurthi, MD, who moderated a press briefing where Le discussed the study. "This is a phase II study, but it is the first randomized study of immunotherapy in metastatic pancreatic cancer demonstrating improved survival," said Krishnamurthi, of University Hospitals Case Medical Center in Cleveland. "This was accomplished without the toxicity of chemotherapy."
Cryoablation Therapy offers Relief to Metastatic Cancer Patients
A study led by Dr. J. David Prologo, Assistant Professor of Interventional Radiology at CWRU and University Hospitals Case Medical Center, found that metastatic cancer patients who received cryoablation therapy – a treatment that freezes and destroys abnormal or cancerous cells with the use of liquid nitrogen – reported significant decreases in pain. The study found that most patients felt relief from pain immediately after the one-time treatment, and that the results lasted for at least three months. Patients also reported a decrease in the amount pain medication needed.
Angela Ting, PhD Receives Ovarian Cancer Research Funding from Colleen's Dream Foundation
Cancer Center member Dr. Angela Ting, Assistant Staff in the Cleveland Clinic Genetic Medicine Institute, received funding from Colleen's Dream Foundation to support ovarian cancer research. According to a news release, one of Dr. Ting's research goals is to establish an epigenetic signature for chemo-resistance in ovarian cancer.
SAVE THE DATE
Screening for Cancer in Women: 2014
Please mark your calendars and plan to attend Screening for Cancer in Women: 2014, on Wednesday, May 21 from 8 am - 3 pm at the Embassy Suites Hotel in Independence.
Optimal strategies in cancer screening and detection are constantly evolving and best practices are changing.
This update is aimed at primary care providers and cancer specialists with guides that can be incorporated into their practices:
- New screening technologies, particularly to detect breast and lung cancer
- Current guidelines for colorectal, skin, lung, breast, and cervical cancer screening
- Impact of the Affordable Care Act and racial and economic disparities on cancer detection
- When to refer a patient for a genetics referral or to a high-risk clinic
CME credit will be offered. Pre-registration is required. Check the Cancer Center website for more information.
NIH Center for Accelerated Innovations at Cleveland Clinic Technology Development Program
The NIH Center for Accelerated Innovations (NCAI) at Cleveland Clinic is offering funding for promising emerging technologies in order to facilitate their translation to commercialized products that improve patient care and enhance health. Proposals are accepted from investigators at NCAI partner institutions Cleveland Clinic, CWRU, Ohio State University, University of Cincinnati, and Cincinnati Children's Hospital Medical Center.
LOI Deadline: February 3
Bladder Cancer Research Innovation Award
The Bladder Cancer Advocacy Network is accepting applications for the 2014 Bladder Cancer Research Innovation Award. The aim of this award is to support exceptionally novel and creative projects with great potential to produce breakthroughs in the management of bladder cancer. Proposals will be accepted for creative ideas and innovative approaches that have direct application and relevance to bladder cancer.
LOI Deadline: February 12
Application Deadline: April 23
CWRU Department of Medicine Team Science Challenge
The CWRU Department of Medicine is delighted to announce Team Science Challenge grants. These grants are meant to encourage applicants for scientific projects that include PIs from more than one division within the Department of Medicine and/or other departments in the university.
Deadline: March 1
Childhood Brain Tumor Foundation
The Childhood Brain Tumor Foundation is soliciting grant applications for the calendar year 2014. There will be two categories of awards:
- Pediatric Brain Tumor Grant Awards: Our standard grant request for pediatric brain tumor awards will continue as usual. We anticipate funding up to three (3) research proposals that are a maximum of two years in duration.
Deadline: March 14
- Astrocytoma Research Award: We have specific funds for one, 1-year research proposal related to all grades of astrocytoma.
Deadline: March 14
Damon Runyon Fellowship Awards
The Damon Runyon Cancer Research Foundation is accepting applications for the following fellowship opportunities:
- Damon Runyon-Sohn Pediatric Cancer Fellowship Award: The Damon Runyon Cancer Research Foundation has joined together with the Sohn Conference Foundation, dedicated to curing pediatric cancers, to establish the Damon Runyon-Sohn Pediatric Cancer Fellowship Award. This award provides funding to basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis or treatment of one or more pediatric cancers.
Deadline: March 17
- Damon Runyon Fellowship Award: The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention.
Deadline: March 17 and August 15
Applicants may apply for either the Damon Runyon Postdoctoral Fellowship Award or the Damon Runyon-Sohn Pediatric Fellowship Award, not for both. Candidates must apply for these fellowships under the guidance of a Sponsor – a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow. In addition to aiding in the planning, execution and supervision of the proposed research, the Sponsor's role is to foster the development of the Fellow's overall knowledge, technical and analytical skills, and capacity for scientific inquiry. The Sponsor is also expected to assist the Fellow in attaining his/her career goals.
Brian Werbel Memorial Fund
Applications are currently being accepted for summer cancer research fellowship funding, provided by the Brian Werbel Memorial Fund. This fund was established in 2007 at University Hospitals Case Medical Center, and is dedicated to providing summer fellows an opportunity to focus on cancer research, with the ultimate goal to aid in curing cancer. Brian's hope was to find a cure for cancer – to make a difference in the world, just as he made a difference in the lives of everyone he touched. Applicants must be conducting cancer research with a Case Comprehensive Cancer Center member. Awardees are required to attend the Annual Golf Outing Event, typically held in July.
Deadline: April 25